Last reviewed · How we verify
LIT-00814
At a glance
| Generic name | LIT-00814 |
|---|---|
| Sponsor | LittDD Medicines Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Phase I Clinical Trial to Evaluate LIT-00814 Tablets in Patients With Advanced Solid Tumor (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LIT-00814 CI brief — competitive landscape report
- LIT-00814 updates RSS · CI watch RSS
- LittDD Medicines Ltd portfolio CI